Senate Democrats preview vaccine arguments ahead of RFK Jr. hearings

Taking stock of the drug industry, from the lab to the medicine chest

January 23, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

MANDEL NGAN/AFP via Getty Images STAT+ | Senate Democrats preview vaccine arguments ahead of RFK Jr. hearings That Bernie Sanders convened the event is telling, as he has widely been viewed as a lawmaker who could potentially support RFK Jr. By Rachel Cohrs Zhang STAT+ | What to watch on Akero's MASH-cirrhosis study results next month In this week's newsletter, we take a look at an upcoming readout from Akero Therapeutics and check in on the commercial launch of Madrigal's Rezdiffra. By Adam Feuerstein STAT+ | RFK Jr., an investor in a CRISPR biotech, has raised alarms about the technology His comments about the gene-editing technology raise a question about how he would regulate it as head of HHS. By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser